News
06-17-2019, 05:07 AM
According to the Mayo Clinic, about 20% of breast cancers make abnormally high levels of a protein called human epidermal growth factor receptor 2 (HER2).
More... (https://www.news-medical.net/news/20190617/Researchers-develop-DNA-nanorobots-that-target-breast-cancer-cells.aspx)
More... (https://www.news-medical.net/news/20190617/Researchers-develop-DNA-nanorobots-that-target-breast-cancer-cells.aspx)